Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.
about
The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus AttenuationNucleic acid aptamers: research tools in disease diagnostics and therapeuticsNew insights into the pathology of podocyte loss: mitotic catastropheRNA plasticity and selectivity applicable to therapeutics and novel biosensor developmentAgarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple ChemokinesStromal cell-derived factor 1 gene polymorphism is associated with susceptibility to adverse long-term allograft outcomes in non-diabetic kidney transplant recipients.Ligand-dependent exponential amplification of a self-replicating L-RNA enzyme.Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal TransplantationAstragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages.Current progress of RNA aptamer-based therapeutics.Using aptamers for cancer biomarker discovery.Targeting complement component 5a promotes vascular integrity and limits airway remodelingPodocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGSBinding of a structured D-RNA molecule by an L-RNA aptamer.Targeting chemokines in proteinuria-induced renal disease.Danger control programs cause tissue injury and remodeling.The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.The signaling pathway of stromal cell-derived factor-1 and its role in kidney diseases.Renal progenitors and childhood: from development to disorders.Role of chemokines in proteinuric kidney disorders.Immune system modulation of kidney regeneration--mechanisms and implications.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.Progenitor cells and podocyte regeneration.Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis.Stem cell therapy for kidney disease.Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.Can podocytes be regenerated in adults?New Insights into Podocyte Biology in Glomerular Health and Disease.Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.Aptamers as both drugs and drug-carriers.Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.SDF-1/CXCR4/CXCR7 is pivotal for vascular smooth muscle cell proliferation and chronic allograft vasculopathy.
P2860
Q26795464-910D4691-B381-4053-990F-5311633364F1Q26824321-CF49640D-315A-4F4D-86FA-FE577FAF12B1Q26991667-09A68BB4-3D75-45C1-86B1-43C033A17BDEQ28727743-C225C5F7-2305-4196-B598-C6FF6900D888Q30850587-B702740A-B8F1-4CED-B2EB-43C5B994F349Q34072441-C56DEFBD-D0A9-4342-B4FA-837DFAF3DF2AQ35975936-ECB18AF6-B6C0-4BD7-8805-5098F0F6759AQ36184345-1CA709A2-CFC9-42DC-80E5-4BFB12848F80Q36197219-C84A366B-BBE7-4DFC-8723-EB0B4604E8ADQ36365202-17493D92-DC8E-4E43-B375-3E1BC44B1FB3Q36582427-FD3F1484-CA7B-45E9-8F7D-3DD7C1CEC56AQ36762599-E0AC868E-C52D-4435-B979-6CD1D64E0E90Q36923664-C0147E83-9771-405C-A101-CB0193C2E8E4Q37245220-FF1BEFC6-9246-4D13-A26A-C7C4989EF37BQ38026076-CB5F9D7E-930A-40BF-86D6-4A408C3B824EQ38113929-57C12B45-FFD0-4C19-9FE2-8BCAB7A2CC05Q38144642-E6626890-435D-4137-AFA0-F3155AB2A69AQ38168568-AA8D3158-CA74-410B-AA48-163782284DC2Q38175781-A249CC31-F8AB-41DC-AE8C-DA66F0032910Q38188747-7E567D8B-191B-44BB-B747-E696026B4967Q38207847-A6B1378E-B903-4B96-8B51-774B7FBB4D11Q38209811-D5421F50-E571-4626-BF44-B2C8E774622AQ38236202-06F871CC-21BE-4229-AE32-9DD2F50D853CQ38248789-1D5E7E68-6C23-442C-A7AD-4C1A85BE1D06Q38307041-75B976FC-A654-4D05-A7A7-D7882D4A9A67Q38544667-15F9E053-C651-4F7A-AFDD-BBA0865EADC1Q38692356-F46224F8-E04E-4993-A84F-28BD6E25C79CQ39183991-C5D532F4-F6BE-4F27-9E36-87F754E45828Q39238888-C9C1228B-6B7E-4FB5-916F-83E3178B517DQ39603954-F16E4768-FB96-4500-8B89-391B351E31FAQ40322521-4C3100FA-D6C5-436E-AFC7-BF7F15D7B7A5Q42236644-62533B83-D77D-4567-B9AC-116A5140BA9CQ47265349-5A2A4AED-7579-4445-A0D8-4B7EAEAF4A22Q47328605-64FC468B-DED1-46A7-AAF6-07A5D6663CBFQ52649284-3083B53C-A375-4316-886B-FF461977F216Q52863308-DFE535D4-19A7-4F23-9994-BB7361D06441
P2860
Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Dual blockade of the homeostat ...... ts on diabetic kidney disease.
@en
type
label
Dual blockade of the homeostat ...... ts on diabetic kidney disease.
@en
prefLabel
Dual blockade of the homeostat ...... ts on diabetic kidney disease.
@en
P2093
P2860
P1476
Dual blockade of the homeostat ...... cts on diabetic kidney disease
@en
P2093
Adriana Migliorini
Axel Vater
Costanza Sagrinati
Dirk Eulberg
Eliana Parente
Murthy N Darisipudi
Onkar P Kulkarni
Sufyan G Sayyed
Sven Klussmann
P2860
P304
P356
10.1016/J.AJPATH.2011.03.004
P407
P577
2011-04-30T00:00:00Z